Press Releases

Telehealth Market: Slow to Start, but Ramp-Up Round the Corner
Date: 01 January 2010

Wellingborough, UK – 1^st January 2010 – A new report from InMedica, on the world market for telehealth, forecasts that the number of gateways used in telehealth applications will increase to over one million in 2014 and to around 3.6 million in 2018. The initiatives taken by governments and private healthcare providers to increase reimbursements and reduce the legal and liability issues will help in the roll out of telehealth as a mainstream technology for remote disease and home-health monitoring. InMedica predicts telehealth will start to be used by healthcare providers on a wider scale from 2012 onwards. This gives a two to three year window for the current market barriers to be overcome, including demonstrating the benefits of telehealth on a large scale to health insurance companies.

In 2009, health hubs were the most widely used telehealth gateways, constituting about 80% of the total gateways market. InMedica believes that in the short to medium term, health hubs will remain the most practical solution for professional healthcare providers to supply to patients, as the infrastructure can then be standardised and simplified on a large scale. Even though the number of integrated cellular handsets used as telehealth gateways was estimated to be small in 2009, they are forecast to grow to over 350 thousand in 2014. According to Neha Khandelwal, market research analyst at InMedica, “The use of mobile phones as telehealth gateways has had a surge of interest over the last couple of years; with patients and device companies recognising the benefits of data transmission on the move. We anticipate that cellular service providers will play an increasingly important role in the long-term future of the telehealth market.”

InMedica forecasts that health hubs will increasingly be for managing disease conditions such as CHF and COPD. However, for disease conditions such as diabetes, cellular handsets will find an increasing acceptance. A number of device companies have launched diabetes management programs that use cellular handsets for transmitting blood-glucose readings to care professionals. Sufferers of diabetes are already used to regular self-monitoring with blood glucose meters. Progressing to a telehealth service will not be a massive lifestyle change for them, so compliance should not be a huge hurdle. Moreover, receiving regular feedback on their condition would be a great benefit.

Contacting Us

Jonathan Cassell
Senior Manager, Editorial
jonathan.cassell@ihs.com
Direct: + 1 408 654 1714
Mobile: + 408 921 3754

Or

IHS Media Relations
press@ihs.com
Direct: +1 303 305 8021

About IHS Inc. (www.ihs.com)

IHS (NYSE: IHS) is the leading source of information, insight and analytics in critical areas that shape today’s business landscape. Businesses and governments in more than 165 countries around the globe rely on the comprehensive content, expert independent analysis and flexible delivery methods of IHS to make high-impact decisions and develop strategies with speed and confidence. IHS has been in business since 1959 and became a publicly traded company on the New York Stock Exchange in 2005. Headquartered in Englewood, Colorado, USA, IHS is committed to sustainable, profitable growth and employs more than 6,000 people in 31 countries around the world.

IHS is a registered trademark of IHS Inc. All other company and product names may be trademarks of their respective owners. Copyright © 2013 IHS Inc. All rights reserved.

Related Reports

• Japan
• China
• Twitter